Boundless Bio Inc. BOLD 深 沪
等待开盘 05-22 09:30:00 美东时间
1.45
+0.030
+2.11%
华盛通- 最 高1.465
- 今 开1.42
- 成交量 3.96万股
- 最 低 1.41
- 昨 收 1.42
- 总市值 3257.30万
- 52周最高 1.68
- 市盈率 静 --
- 换手率 0.18%
- 52周最低 0.9612
- 委 比 74.75%
- 总股本 2246.41万
- 历史最高 15.24
- 量 比 0.25
- 振 幅 3.87%
- 历史最低 0.9612
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Boundless Bio Q1 EPS $(0.60) Beats $(0.64) Estimate
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.64) by 4.76 percent. This is a 15.49 percent increase over losses of $(0.71) per share from the
05-08 19:11
Boundless Bio Reveals Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers,
04-18 04:52
Boundless Bio Terminates Major Long-Term San Diego Lease
The latest announcement is out from Boundless Bio Inc. ( ($BOLD) ). On April 13...
04-14 05:55
Boundless Bio To Present Oral Kinesin Degrader Program At The AACR Annual Meeting 2026
Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers,
03-18 04:55
Boundless Bio Q4 EPS $(0.58) Misses $(0.52) Estimate
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.52) by 11.54 percent. This is a 21.62 percent increase over losses of $(0.74) per share from
03-09 19:13
Boundless Bio CEO Zachary Hornby to Join Fireside Chat at Leerink Global Healthcare Conference
Boundless Bio CEO Zachary Hornby to Join Fireside Chat at Leerink Global Healthcare Conference Boundless Bio (Nasdaq: BOLD) said its President and CEO Zachary Hornby will participate in a fireside chat at the Leerink Global Healthcare Conference on Wednesday, March 11, 2026 at 11:20 a.m. ET in Miami
03-04 20:02
Boundless Bio Terminates Early-Stage BBI-825 Cancer Trial: What Investors Should Know
Boundless Bio Inc. ($BOLD) announced an update on their ongoing clinical study....
01-17 00:31
Boundless Bio Unveils New Therapies Targeting ecDNA-Driven Cancer
Boundless Bio Inc. has released a corporate presentation detailing its latest advancements in cancer treatment through ecDNA-directed therapies (ecDTx). The company highlights the significant unmet me...
2025-11-11 02:51
Boundless Bio Q3 EPS $(0.62) Misses $(0.53) Estimate
Boundless Bio (NASDAQ:BOLD) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.53) by 16.32 percent. This is a 16.22 percent increase over losses of $(0.74) per share from
2025-11-05 20:08
Boundless Bio posts Q3 net loss of $13.9 million on $117.6 million cash balance
Boundless Bio Inc. reported a cash, cash equivalents, and short-term investments balance of $117.6 million as of September 30, 2025. Research and development expenses for the third quarter of 2025 wer...
2025-11-05 20:01
